SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-012803
Filing Date
2023-04-18
Accepted
2023-04-18 17:00:26
Documents
29
Period of Report
2023-04-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44354
2 ex99-1.htm EX-99.1 29871
3 ex99-2.htm EX-99.2 12593
4 ex99-2_001.jpg GRAPHIC 214477
5 ex99-2_002.jpg GRAPHIC 341238
6 ex99-2_003.jpg GRAPHIC 408611
7 ex99-2_004.jpg GRAPHIC 279455
8 ex99-2_005.jpg GRAPHIC 406381
9 ex99-2_006.jpg GRAPHIC 406522
10 ex99-2_007.jpg GRAPHIC 214144
11 ex99-2_008.jpg GRAPHIC 335653
12 ex99-2_009.jpg GRAPHIC 341161
13 ex99-2_010.jpg GRAPHIC 328651
14 ex99-2_011.jpg GRAPHIC 360303
15 ex99-2_012.jpg GRAPHIC 334951
16 ex99-2_013.jpg GRAPHIC 319710
17 ex99-2_014.jpg GRAPHIC 267624
18 ex99-2_015.jpg GRAPHIC 408715
  Complete submission text file 0001493152-23-012803.txt   7115538

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE sonn-20230418.xsd EX-101.SCH 3230
20 XBRL LABEL FILE sonn-20230418_lab.xml EX-101.LAB 34240
21 XBRL PRESENTATION FILE sonn-20230418_pre.xml EX-101.PRE 22361
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3630
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 23827570
SIC: 2834 Pharmaceutical Preparations